The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Our coverage of lawmakers' attempts to block FCC licenses for future drones from DJI featured heavily in our 'most read' list ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Pharmaceuticals for the development of a potential. “We are pleased to partner with Amylyx to advance GLP-1 receptor antagonism research. This collaboration and development agreement is an example of ...

The Fortune 500 company will be adding an "On Track" badge to 26 of its Healthy Choice frozen food items in an effort to ...

Nestlé released a similar announcement on September 18, 2024, revealing an entirely new line of GLP-1-friendly foods under ...

Studies are limited, but health experts say imbibing on a GLP-1 drug can carry some theoretical risks. Here are 7 things to ...

Amylyx Pharmaceuticals Inc ( (AMLX) ) has provided an update.